|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4709 | (2006.01) |
| A61K 31/4709 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3400942 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17735839.7 |
| Europos patento paraiškos padavimo data | 2017-01-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/070352 |
| Data | 2017-01-06 |
| (87) | Numeris | WO 2017/118401 |
| Data | 2017-07-13 |
| (30) | Numeris | Data | Šalis |
| 201610013628 | 2016-01-08 | CN |
| (72) |
WANG, Xunqiang , CN
YANG, Ling , CN
XU, Zhongnan , CN
WANG, Xiangjian , CN
GENG, Wenjun , CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ,
No. 369 Yuzhou South Rd., Lianyungang City, Jiangsu 222062,
CN
|
| (54) | USE OF QUINOLINE DERIVATIVES FOR TREATING OESOPHAGEAL CANCER AND TREATMENT METHOD, PHARMACEUTICAL COMPOSITION AND KIT THEREOF |
| USE OF QUINOLINE DERIVATIVES FOR TREATING OESOPHAGEAL CANCER AND TREATMENT METHOD, PHARMACEUTICAL COMPOSITION AND KIT THEREOF |